hexapropymate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 9661 |
| CHEMBL ID | 2104292 |
| CHEBI ID | 134823 |
| SCHEMBL ID | 1550506 |
| MeSH ID | M0041485 |
| Synonym |
|---|
| modirax |
| nsc-169094 |
| hexapropymate |
| lunamin |
| l2103 |
| carbamic acid, 1-(2-propynyl)cyclohexyl ester |
| 1-(2-propynyl)cyclohexanol carbamate |
| propynylcyclohexanol carbamate |
| nsc169094 |
| 1-(2-propynyl)cyclohexyl carbamate |
| wln: l6tj aovz a2uu1 |
| l 2103 |
| merinax |
| esapropimato |
| 1-carbamoyloxy-1-(2-propynyl)cyclohexane |
| 358-52-1 |
| 1-(2-propynyl)-1-cyclohexanol carbamate |
| hexopropynate |
| lf 62 |
| l-2103 , |
| hexapropimato [inn-spanish] |
| brn 3253991 |
| hexapropymate [inn:ban:dcf] |
| carbamate du propinylcyclohexanol [french] |
| nsc 169094 |
| cyclohexanol, 1-(2-propynyl)-, carbamate |
| hexapropymatum [inn-latin] |
| einecs 206-618-9 |
| merinax (tn) |
| D07331 |
| hexapropymate (inn) |
| CHEBI:134823 |
| (1-prop-2-ynylcyclohexyl) carbamate |
| hexapropimato |
| unii-0j9rn2prj7 |
| 0j9rn2prj7 , |
| hexapropymatum |
| carbamate du propinylcyclohexanol |
| 4-06-00-00362 (beilstein handbook reference) |
| AKOS006240457 |
| CHEMBL2104292 |
| FT-0603383 |
| hexapropymate [who-dd] |
| hexapropymate [inn] |
| hexapropymate [mi] |
| hexapropymate [mart.] |
| SCHEMBL1550506 |
| DTXSID00189329 |
| 1-(prop-2-yn-1-yl)cyclohexyl carbamate |
| 1-(prop-2-ynyl)cyclohexyl carbamate |
| Z995241878 |
| DB13662 |
| Q1036070 |
| lunamin; l2103; nsc 169094 |
| EN300-1266505 |
| Class | Description |
|---|---|
| carbamate ester | Any ester of carbamic acid or its N-substituted derivatives. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||